SCHEMBL23965792

SCHEMBL23965792

c1ccc2sc(N3CC(OCC4CCCO4)C3)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
LMNA P02545 3/20 0.52
TSHR P16473 3/20 0.52
NPC1 O15118 8/20 0.51
RAB9A P51151 8/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
POLB P06746 3/20 0.51
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 4/20 0.47
PDE10A Q9Y233 2/20 0.47
TP53 P04637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 2/20 0.47
USP2 O75604 3/20 0.47
GAA P10253 1/20 0.46
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21638262 0.85 NPC1 (0.51) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL23965809 0.77 RAB9A (0.57) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL21697464 0.76 MEN1 (0.49) ALDH1A1LMNATSHRSMN1; SMN2MEN1
SCHEMBL23965814 0.75 PDE10A (0.50) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL23965751 0.73 RAB9A (0.54) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL23965743 0.72 MAPT (0.53) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL6400788 0.70 RAB9A (0.54) LMNATSHRNPC1RAB9ASMN1; SMN2
SCHEMBL29234950 0.70 RAB9A (0.57) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL23965820 0.70 ACACB (0.55) ALDH1A1LMNATSHRNPC1RAB9A
SCHEMBL23965808 0.70 RAB9A (0.50) ALDH1A1TSHRNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB ALDH1A1 2347/4885LMNA 1923/4885TSHR 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.